As Ibm (IBM) Share Value Declined, Shareholder Ls Investment Advisors Has Lowered by $1.06 Million Its Holding; Edgewood Management Position in Celgene (CELG) Raised by $101.57 Million as Valuation Declined

May 23, 2018 - By Winifred Garcia

Celgene Corporation (NASDAQ:CELG) Logo

Edgewood Management Llc increased its stake in Celgene Corp (CELG) by 9.25% based on its latest 2017Q4 regulatory filing with the SEC. Edgewood Management Llc bought 976,596 shares as the company’s stock declined 19.30% with the market. The institutional investor held 11.53 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.20B, up from 10.56M at the end of the previous reported quarter. Edgewood Management Llc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $56.37B market cap company. The stock increased 1.31% or $1 during the last trading session, reaching $77.61. About 4.28M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 23, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Ls Investment Advisors Llc decreased its stake in Ibm (IBM) by 17.79% based on its latest 2017Q4 regulatory filing with the SEC. Ls Investment Advisors Llc sold 6,896 shares as the company’s stock declined 0.39% with the market. The institutional investor held 31,865 shares of the computer manufacturing company at the end of 2017Q4, valued at $4.89M, down from 38,761 at the end of the previous reported quarter. Ls Investment Advisors Llc who had been investing in Ibm for a number of months, seems to be less bullish one the $132.19 billion market cap company. The stock decreased 0.75% or $1.09 during the last trading session, reaching $144. About 1.66M shares traded. International Business Machines Corporation (NYSE:IBM) has declined 12.58% since May 23, 2017 and is downtrending. It has underperformed by 24.13% the S&P500.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Seekingalpha.com which released: “Is Celgene’s Stock A Buy The Dip Opportunity?” on May 23, 2018, also Nasdaq.com with their article: “3 Biotechs on the FDA’s Naughty List That Should Be on Investors’ Buy Lists” published on May 22, 2018, Finance.Yahoo.com published: “Celgene Corporation: How to Effectively Buy Into CELG Stock” on May 22, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Benzinga.com and their article: “Celgene Wins One Bull, Loses Another On Revlimid Potential” published on May 23, 2018 as well as Seekingalpha.com‘s news article titled: “Premarket analyst action – healthcare” with publication date: May 23, 2018.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It dropped, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Renaissance Lc has 0.09% invested in Celgene Corporation (NASDAQ:CELG) for 796,200 shares. Woodstock accumulated 100,073 shares. 43,772 are owned by Synovus Corporation. Adams Asset Advsrs Ltd Com owns 8,500 shares or 0.11% of their US portfolio. Tanaka Cap stated it has 1.69% of its portfolio in Celgene Corporation (NASDAQ:CELG). Etrade Cap Mngmt Lc reported 0.09% of its portfolio in Celgene Corporation (NASDAQ:CELG). Perkins Coie Trust owns 462 shares for 0.02% of their portfolio. Mackenzie holds 0.03% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 124,642 shares. Clearbridge Investments Limited Liability Corporation holds 0.61% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 6.32M shares. Bridgewater Assocs Ltd Partnership, Connecticut-based fund reported 290,776 shares. Md Sass Inc has 301,389 shares for 2.81% of their portfolio. 169,526 are owned by Penn Davis Mcfarland. Florida-based Raymond James Services Advisors has invested 0.34% in Celgene Corporation (NASDAQ:CELG). Aldebaran Inc invested in 0.75% or 10,875 shares. Intact Inv Management, Ontario – Canada-based fund reported 5,000 shares.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 146 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Wednesday, February 28 by Credit Suisse. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, July 6 report. UBS maintained the stock with “Buy” rating in Friday, October 27 report. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Friday, July 15 by Stifel Nicolaus. The firm has “Buy” rating by Credit Suisse given on Monday, October 30. The firm has “Buy” rating by Guggenheim given on Monday, October 23. As per Monday, October 23, the company rating was maintained by Morgan Stanley. The firm has “Buy” rating given on Wednesday, December 13 by Leerink Swann. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, April 13. The firm has “Outperform” rating given on Friday, December 4 by Wells Fargo.

Since February 8, 2018, it had 2 insider buys, and 3 selling transactions for $3.48 million activity. KAPLAN GILLA sold 18,500 shares worth $1.77 million. 9,250 Celgene Corporation (NASDAQ:CELG) shares with value of $851,093 were sold by LOUGHLIN JAMES J. Alles Mark J had bought 1,208 shares worth $99,784.

Edgewood Management Llc, which manages about $9.25B and $22.97B US Long portfolio, decreased its stake in Apple Inc (NASDAQ:AAPL) by 3,113 shares to 166,229 shares, valued at $28.13 million in 2017Q4, according to the filing. It also reduced its holding in Cme Group Inc (NASDAQ:CME) by 310,280 shares in the quarter, leaving it with 7.37M shares, and cut its stake in Paypal Hldgs Inc.

Analysts await International Business Machines Corporation (NYSE:IBM) to report earnings on July, 17. They expect $3.03 earnings per share, up 2.02% or $0.06 from last year’s $2.97 per share. IBM’s profit will be $2.78 billion for 11.88 P/E if the $3.03 EPS becomes a reality. After $2.45 actual earnings per share reported by International Business Machines Corporation for the previous quarter, Wall Street now forecasts 23.67% EPS growth.

More notable recent International Business Machines Corporation (NYSE:IBM) news were published by: Fool.com which released: “Buffett’s 3 Most Important Stock Sales in 2018” on May 21, 2018, also Seekingalpha.com with their article: “AMD: Ready For Server Outperformance?” published on May 23, 2018, Wallstreetpr.com published: “Stellar Lumens Intends To Host The First Token By IBM (NYSE:IBM) On The XLM Blockchain Technology” on May 22, 2018. More interesting news about International Business Machines Corporation (NYSE:IBM) were released by: Seekingalpha.com and their article: “IBM: Weak Dividend Raise?” published on April 24, 2018 as well as Seekingalpha.com‘s news article titled: “IBM And Its Deceiving Dividend” with publication date: May 07, 2018.

Ls Investment Advisors Llc, which manages about $1.86 billion and $1.72 billion US Long portfolio, upped its stake in Altria Group Inc (NYSE:MO) by 7,055 shares to 48,069 shares, valued at $3.43M in 2017Q4, according to the filing. It also increased its holding in Vanguard Small (VBR) by 3,750 shares in the quarter, for a total of 38,198 shares, and has risen its stake in Becton Dickinson & Co (NYSE:BDX).

Since January 31, 2018, it had 1 insider buy, and 2 sales for $2.69 million activity. $780,000 worth of International Business Machines Corporation (NYSE:IBM) shares were sold by Gherson Diane J. Clementi Erich sold $2.01M worth of stock.

Investors sentiment increased to 1.03 in Q4 2017. Its up 0.29, from 0.74 in 2017Q3. It improved, as 54 investors sold IBM shares while 604 reduced holdings. 156 funds opened positions while 519 raised stakes. 504.07 million shares or 2.90% less from 519.10 million shares in 2017Q3 were reported. Bridges Investment Counsel reported 3.14% of its portfolio in International Business Machines Corporation (NYSE:IBM). Coastline Trust invested in 15,853 shares. Diversified Tru holds 0.03% or 3,525 shares in its portfolio. Deprince Race And Zollo holds 0.58% in International Business Machines Corporation (NYSE:IBM) or 170,389 shares. Zevin Asset Mngmt Limited Liability accumulated 8,368 shares. Milestone Gp owns 1,928 shares or 0.05% of their US portfolio. Pictet & Cie (Europe) stated it has 0.14% in International Business Machines Corporation (NYSE:IBM). 5,850 were accumulated by Dreman Value Mgmt L L C. Hudock Gru Limited Company holds 0.69% or 10,358 shares. 1,160 are held by First Financial In. Creative Planning owns 0.12% invested in International Business Machines Corporation (NYSE:IBM) for 183,107 shares. Williams Jones Assoc Limited Liability Company invested in 0.19% or 53,588 shares. Moreover, Woodmont Invest Counsel has 0.08% invested in International Business Machines Corporation (NYSE:IBM) for 1,982 shares. Moreover, Earnest Prtnrs Llc has 0.08% invested in International Business Machines Corporation (NYSE:IBM). John G Ullman & reported 2.05% of its portfolio in International Business Machines Corporation (NYSE:IBM).

Among 33 analysts covering International Business Machines (NYSE:IBM), 13 have Buy rating, 4 Sell and 16 Hold. Therefore 39% are positive. International Business Machines had 129 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Sector Perform” rating on Monday, January 18 by RBC Capital Markets. As per Thursday, January 18, the company rating was maintained by Bank of America. The rating was maintained by UBS on Wednesday, October 18 with “Neutral”. As per Wednesday, August 26, the company rating was upgraded by Argus Research. RBC Capital Markets maintained it with “Hold” rating and $16000 target in Tuesday, August 15 report. The stock has “Hold” rating by KeyBanc Capital Markets on Tuesday, August 22. The rating was maintained by RBC Capital Markets on Friday, January 15 with “Sector Perform”. The stock has “Underperform” rating by Credit Suisse on Wednesday, October 12. JP Morgan maintained it with “Neutral” rating and $159 target in Tuesday, April 19 report. The stock of International Business Machines Corporation (NYSE:IBM) earned “Hold” rating by KeyBanc Capital Markets on Monday, September 25.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>